<code id='D227FE5A85'></code><style id='D227FE5A85'></style>
    • <acronym id='D227FE5A85'></acronym>
      <center id='D227FE5A85'><center id='D227FE5A85'><tfoot id='D227FE5A85'></tfoot></center><abbr id='D227FE5A85'><dir id='D227FE5A85'><tfoot id='D227FE5A85'></tfoot><noframes id='D227FE5A85'>

    • <optgroup id='D227FE5A85'><strike id='D227FE5A85'><sup id='D227FE5A85'></sup></strike><code id='D227FE5A85'></code></optgroup>
        1. <b id='D227FE5A85'><label id='D227FE5A85'><select id='D227FE5A85'><dt id='D227FE5A85'><span id='D227FE5A85'></span></dt></select></label></b><u id='D227FE5A85'></u>
          <i id='D227FE5A85'><strike id='D227FE5A85'><tt id='D227FE5A85'><pre id='D227FE5A85'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:focus    Page View:5818
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In